First-line Pembrolizumab Plus Chemotherapy May Benefit Patients with Advanced Biliary Tract CancersThe addition of pembrolizumab (Keytruda) to gemcitabine and cisplatin improved overall survival in patients with untreated metastatic or unresectable biliary tract cancer, according to results from the phase III KEYNOTE-966 clinical trial.
Advanced Heart Failure Clinic at Walnut CreekThrough a collaboration between John Muir Health and UCSF Health, patients with advanced heart failure have access to specialized care in Walnut Creek.
Alcohol-Associated Liver Disease ProgramUCSF HEPATOLOGY AND LIVER TRANSPLANT SERVICES have established the Alcohol-Associated Liver Disease Program, expanding access to hepatology care and liver transplantation for a broader range of patients.
Interventional Cardiology ProgramThe UCSF Interventional Cardiology Program offers the latest minimally invasive catheter-based procedures to diagnose and treat the full spectrum of cardiovascular conditions.
Cardio-Oncology & Immunology: Specialized Cardiovascular Care for Cancer PatientsLed by a multidisciplinary team of specialists and researchers, our program optimizes the cardiovascular health of cancer patients and cancer survivors.
UCSF Interventional Cardiology Experts Perform Novel Tricuspid and Mitral Valve ProceduresUC San Francisco interventional cardiologists and interventional echocardiographers recently performed two novel minimally invasive cardiac procedures for the first time in the health system.
Patients With Detectable PSA After Radical Prostatectomy Have Good Long-Term Outcomes, UCSF Researchers FindPatients with a detectable prostate-specific antigen (PSA) after radical prostatectomy (RP) may have excellent long-term outcomes, according to two retrospective studies conducted by UCSF researchers.
Chances of Receiving Percutaneous Coronary Intervention in a Low-Volume Facility are Increasing, Despite Worse OutcomesThere is a well-established association between hospitals performing higher volumes of percutaneous coronary intervention (PCI) and improved patient outcomes.
Susceptibility to Pathogenic T Cells in Chronic Lung Disease May have a Genetic BasisRespiratory viral infections pose significant morbidity and mortality to patients with chronic lung diseases like emphysema and COPD, causing exacerbations that drive destruction of normal lung tissue, and leading to one of the most common diagnoses for hospital admissions.
UCSF Surgical Oncologists Present Clinical Findings at International ConferenceThe latest advances in surgical cancer care and research were showcased at the Society of Surgical Oncology’s (SSO) Annual Meeting, the International Conference on Surgical Cancer Care. The meeting was held in Boston, from March 22 – 25, 2023.
How the Cardiogenic Shock Team Improves Patient Outcomes at UCSFA 69-year-old woman with heart failure with reduced ejection fraction caused by left ventricular noncompaction (LVNC) came to the UCSF emergency department with tachycardia, dizziness, shortness of breath and swelling, despite taking all prescribed heart failure medications.
Some Patients with Lung Disease Fare Worse Than Others. Could Sleep Explain It?Flare-Ups in COPD Linked to Sleeplessness, UCSF-Led Study Shows
Center for Encephalitis and MeningitisThe UCSF Center for Encephalitis and Meningitis provides comprehensive services to diagnose and treat patients with challenging neuroinflammatory disorders.
UCSF Health Joins Registry to Improve Cardiogenic Shock TreatmentUC San Francisco’s Heart and Vascular Center has been recognized by The American Heart Association (AHA) for its participation in a new Cardiogenic Shock Registry.
UCSF Neurologist Recognized for Innovative Epilepsy ResearchUCSF Neurologist Recognized for Innovative Epilepsy Research American Academy of Neurology to Honor Jon Kleen, MD, PhD with 2023 Dreifuss-Penry Epilepsy Award
Electroconvulsive Therapy for Status Epilepticus and a Genetic Diagnosis for Epilepsy and Renal Failure: UCSF Neurohospitalist CasesOne of the first of its kind, the UCSF Neurohospitalist Program specializes in caring for hospitalized patients with complex neurologic disorders.
In Utero Enzyme Replacement TherapyPregnant patients with a diagnosed fetal lysosomal storage disease may have the opportunity to receive a promising treatment that could improve their babies’ health after birth.
Minimally Invasive LITT Effective for Recurrent Glioblastoma: A UCSF Case StudyA 65-year-old woman with a small focal recurrence of glioblastoma was treated with laser interstitial thermal therapy (LITT) at UCSF nearly five years after her first tumor resection surgery.
Ross Procedure the Right Choice for Active Patient With Aortic StenosisA 52-year-old man with severe aortic stenosis chose to undergo a Ross procedure at UCSF during which surgeons replaced his diseased aortic valve with his own pulmonary valve. He was discharged within a week and is recovering well.
Structural Heart Disease Expert Leads UCSF Interventional Cardiology ProgramSammy Elmariah, MD, MPH, has joined UCSF as chief of the Interventional Cardiology Program and medical director of the cardiac catheterization lab.
UCSF Surgeons Standardize Browlift and Hairline Surgery Using Photo AnalysisFacial Feminization surgery (FFS) involves numerous procedures designed to give the face a more feminine and harmonious appearance.
Killing Pancreatic Cancer with T Cells that Turbocharge ThemselvesNovel Immunotherapy Pumps Out Cancer-Killing Cytokines Only Inside the Tumor
UCSF Bariatric Surgery CenterUCSF Bariatric Surgery Center
Breast Cancer Risk Calculator Can Assess Risk of Advanced Breast CancerUpcoming Conference to Focus on Breast Density and Prediction of Advanced and Interval Breast Cancer Risk